Cutting_JJ
edge_NN
:_:
expression_NN
of_IN
the_DT
NF_NN
of_IN
activated_VBN
T_NN
cells_NNS
in_IN
eosinophils_NNS
:_:
regulation_NN
by_IN
IL-4_NN
and_CC
IL-5_NN
._.

We_PRP
report_VBP
that_IN
NF-AT1_NN
and_CC
NF-AT4_NN
are_VBP
expressed_VBN
cytoplasmically_RB
in_IN
resting_VBG
eosinophils_NNS
,_,
whereas_IN
NF-AT2_NN
and_CC
NF-AT3_NN
have_VBP
not_RB
been_VBN
seen_VBN
._.

Likewise_RB
,_,
NF-AT1_NN
mRNA_NN
and_CC
NF-AT4_NN
mRNA_NN
have_VBP
been_VBN
detected_VBN
in_IN
resting_VBG
eosinophils_NNS
,_,
and_CC
their_PRP$
levels_NNS
can_MD
be_VB
significantly_RB
up-regulated_VBN
by_IN
the_DT
Th2-associated_JJ
cytokines_NNS
IL-4_NN
and_CC
IL-5_NN
._.

There_EX
is_VBZ
no_DT
detectable_JJ
NF-AT_NN
protein_NN
expression_NN
in_IN
the_DT
nuclei_NNS
of_IN
resting_VBG
eosinophils_NNS
._.

However_RB
NF-ATs_NNS
appear_VBP
in_IN
the_DT
nuclei_NNS
of_IN
IL-4_NN
-_:
,_,
IL-5_NN
-_:
,_,
or_CC
ionomycin-stimulated_JJ
eosinophils_NNS
._.

Only_RB
NF-AT1_NN
and_CC
NF-AT4_NN
,_,
but_CC
not_RB
NF-AT2_NN
and_CC
NF-AT3_NN
,_,
have_VBP
translocated_VBN
into_IN
the_DT
nuclei_NNS
in_IN
IL-4_NN
-_:
or_CC
IL-5-stimulated_JJ
eosinophils_NNS
._.

These_DT
findings_NNS
delineate_VBP
a_DT
novel_JJ
pathway_NN
in_IN
the_DT
cytokine_NN
network_NN
in_IN
which_WDT
Th2_NN
lymphocytes_NNS
``_VBZ
control_JJ
''_JJ
eosinophils_NNS
via_IN
the_DT
release_NN
of_IN
IL-4_NN
and_CC
IL-5_NN
,_,
and_CC
activation_NN
of_IN
NF-AT_NN
in_IN
eosinophils_NNS
._.

The_DT
findings_NNS
also_RB
suggest_VBP
that_IN
a_DT
later_JJ
feedback_NN
``_NN
talking_NN
''_NN
may_MD
exist_VB
between_IN
eosinophils_NNS
and_CC
Th2_NN
lymphocytes_NNS
._.

